How to Apply to GlaxoSmithKline Korea

11 min read Last updated April 20, 2026 1 open positions
Blake Crosley
Blake Crosley Researched using publicly available information, hiring data, and ATS analysis.

Key Takeaways

  • GSK Korea is the Korean affiliate of GSK plc (renamed from GlaxoSmithKline in May 2022), now a pure-play biopharma after the 2022 Haleon consumer health spinout.
  • Core therapy areas in Korea: HIV (ViiV), oncology, respiratory and immunology (Trelegy, Nucala, Benlysta), and vaccines (Shingrix, Arexvy) — frame your application around these.
  • Headquartered in Seoul (Yeoksam-dong / Gangnam area) with an estimated 600 to 1,000 employees focused on commercial, medical, market access, regulatory, and clinical operations.
  • Bilingual Korean and English fluency is required for nearly all roles. Submit both Korean and English resumes.
  • Compensation is competitive within Korean multinational pharma — entry-level associates roughly ₩40-55M, mid-level brand or MSL roles ₩60-90M, senior managers ₩100-180M, Director and above ₩200M+.
  • The interview process spans 6 to 10 weeks with recruiter screen, hiring manager interview, panel rounds, and executive panel — scientific credibility and bilingual fluency are non-negotiable.
  • Market access roles require deep HIRA, NHIS, and NECA fluency; medical affairs roles require KOL relationships at top Korean academic medical centers (SNUH, Asan, Samsung, Severance).
  • Work-life balance is generally better than Korean chaebols, with a strong female workforce in commercial and medical functions and structured talent development including international assignment opportunities.

About GlaxoSmithKline Korea

GSK Korea (GSK 한국법인) is the South Korean affiliate of GSK plc (LON: GSK, NYSE: GSK), the major UK-based global biopharmaceutical company headquartered in London. GSK plc renamed from GlaxoSmithKline plc to GSK plc in May 2022 — the rebrand simplified the corporate identity from the longer GlaxoSmithKline name to the shorter GSK as part of a broader corporate transformation. CEO Emma Walmsley has led the company since 2017, becoming the first female CEO of a major global pharmaceutical company. She brought a consumer marketing rigor from her L'Oreal background that has reshaped GSK's commercial discipline. Globally, GSK employs roughly 70,000 people and reported approximately £30 billion in revenue for 2024. The company underwent a defining transformation between 2022 and 2024. In 2022, GSK Consumer Healthcare was spun out as Haleon plc (LON: HLN), a separately listed consumer health company. Brands such as Sensodyne, Panadol, Centrum, Voltaren, Advil, and Theraflu now belong to Haleon, not GSK. As a result, GSK is now a pure-play biopharmaceutical company focused on innovative medicines and vaccines. Its core therapy areas include HIV (through ViiV Healthcare, a joint venture with Pfizer and Shionogi covering treatments and PrEP including the long-acting injectable Apretude), oncology (Jemperli/dostarlimab, Ojjaara, and the returning Blenrep), respiratory and immunology (Trelegy for COPD, Nucala for asthma, Benlysta for lupus), and vaccines (Shingrix for shingles, which delivered roughly £3.4 billion in 2024 sales, plus Arexvy for adult RSV launched in 2023, influenza, hepatitis, and the malaria vaccine Mosquirix). In 2024, GSK and Pfizer settled the long-running Zantac litigation, finally resolving a major US tort liability overhang. GSK Korea, headquartered in Seoul (Yeoksam-dong / Gangnam area), operates as the Korean affiliate handling local marketing, sales, medical affairs, clinical trials, regulatory affairs with the Ministry of Food and Drug Safety (MFDS, formerly KFDA), and market access work with the Health Insurance Review Agency (HIRA), the National Evidence-based healthcare Collaborating Agency (NECA), and the National Health Insurance Service (NHIS). Headcount is estimated in the 600 to 1,000 employee range, typical for a major multinational pharma affiliate in Korea. Major Korean products include Shingrix (대상포진 vaccine, with strong uptake among older Korean adults), Trelegy for COPD, the HIV portfolio, and specialty medicines Nucala and Benlysta. South Korea is one of Asia's most sophisticated pharmaceutical markets — well-regulated, single-payer reimbursement, and home to strong domestic players like Samsung Bioepis, Celltrion, Yuhan, Hanmi, Daewoong, JW Pharmaceutical, Donga ST, and Boryung — making GSK Korea a competitive, scientifically demanding environment.

Application Process

  1. 1
    Search open roles at the GSK Korea careers portal (typically gsk

    Search open roles at the GSK Korea careers portal (typically gsk.com/careers filtered to South Korea, or a localized Korean recruitment site). Many multinational pharma affiliates in Korea use Workday-based global systems with Korean localization.

  2. 2
    Submit a Korean-language resume (이력서) and self-introduction (자기소개서) for most loc

    Submit a Korean-language resume (이력서) and self-introduction (자기소개서) for most local roles, with an English CV attached for regional or global-facing positions. Bilingual application is the norm.

  3. 3
    Initial recruiter screen by phone or video, typically 30 to 45 minutes, conducte

    Initial recruiter screen by phone or video, typically 30 to 45 minutes, conducted in Korean with some English to assess bilingual fluency. Expect questions on motivation, therapy area interest, and salary expectations.

  4. 4
    First hiring manager interview, usually one-on-one with the direct supervisor (B

    First hiring manager interview, usually one-on-one with the direct supervisor (Brand Manager, Medical Director, Market Access Lead, etc.), focused on functional competency and Korean pharma industry experience.

  5. 5
    Panel interviews (typically two to three rounds) with cross-functional stakehold

    Panel interviews (typically two to three rounds) with cross-functional stakeholders. For medical roles expect a Medical Director peer interview; for sales roles a structured role-play; for marketing a brand strategy case study; for regulatory or market access a technical deep-dive on MFDS or HIRA processes.

  6. 6
    Executive panel round with the relevant Business Unit Head or General Manager, o

    Executive panel round with the relevant Business Unit Head or General Manager, often combined with a presentation task tailored to the role (e.g., a launch plan, a KOL engagement plan, or a reimbursement strategy).

  7. 7
    Reference checks with prior managers, typically two to three references from Kor

    Reference checks with prior managers, typically two to three references from Korean pharma industry contacts. GSK Korea takes references seriously given the tight-knit nature of the Korean pharma talent market.

  8. 8
    Offer negotiation handled by HR with input from the hiring manager

    Offer negotiation handled by HR with input from the hiring manager. Total compensation discussions cover base, target bonus, and benefits; stock options are typically reserved for senior or globally-aligned roles.

  9. 9
    Background verification (education, employment history, criminal record check pe

    Background verification (education, employment history, criminal record check per Korean labor law) and pre-employment medical exam where applicable.

  10. 10
    Onboarding with GSK Korea's structured first-90-days program, including global G

    Onboarding with GSK Korea's structured first-90-days program, including global GSK orientation modules, Korean compliance training, and therapy area immersion.

Resume Tips for GlaxoSmithKline Korea

recommended

Lead with your Korean pharma multinational experience — list peer affiliates suc

Lead with your Korean pharma multinational experience — list peer affiliates such as Pfizer Korea, MSD Korea, Roche Korea, Novartis Korea, AbbVie Korea, AstraZeneca Korea, Takeda Korea, Janssen Korea, BMS Korea, Gilead Korea, Sanofi Korea, or Lilly Korea. Switchers from Korean domestic pharma (Yuhan, Hanmi, Daewoong, Samsung Bioepis, Celltrion) should highlight transferable scientific and regulatory skills.

recommended

Call out specific therapeutic area expertise aligned to GSK's portfolio: HIV (a

Call out specific therapeutic area expertise aligned to GSK's portfolio: HIV (a niche Korean specialty), oncology (Jemperli/dostarlimab and PD-1/L1 experience), respiratory (COPD, asthma), vaccines (Shingrix and adult immunization familiarity), and immunology (Benlysta lupus, Nucala severe asthma).

recommended

Highlight Korean medical credentials prominently — MD, PharmD, or PhD for medica

Highlight Korean medical credentials prominently — MD, PharmD, or PhD for medical affairs and MSL roles; pharmacy degrees from Seoul National University, Sungkyunkwan, Ewha Womans University, or other top Korean pharmacy programs for regulatory and market access roles.

recommended

For commercial roles, document your Korean key opinion leader (KOL) relationship

For commercial roles, document your Korean key opinion leader (KOL) relationships at top-tier hospitals — Seoul National University Hospital (서울대학교병원), Asan Medical Center (서울아산병원), Samsung Medical Center (삼성서울병원), and Severance (세브란스). Specific KOL names should not appear, but therapy area coverage should.

recommended

Quantify achievements in Korean Won and percentages — sales growth, market share

Quantify achievements in Korean Won and percentages — sales growth, market share gains, NHIS listing wins, MFDS approval timelines, MSL coverage metrics, and KOL engagement frequencies.

recommended

Demonstrate MFDS regulatory experience explicitly: NDA filings, sBLA-equivalent

Demonstrate MFDS regulatory experience explicitly: NDA filings, sBLA-equivalent biologics submissions, label changes, vaccine batch releases, and post-marketing surveillance per KFDA legacy + current MFDS frameworks.

recommended

For market access candidates, document HIRA negotiation experience, NECA HTA sub

For market access candidates, document HIRA negotiation experience, NECA HTA submissions, NHIS pricing strategy, and risk-sharing agreement (RSA) experience — these are the technical fluencies that distinguish strong Korean market access talent.

recommended

State your Korean and English proficiency clearly

State your Korean and English proficiency clearly. Korean is essential for nearly all roles. English fluency is required for regional APAC (Singapore HQ) and global GSK communications — TOEIC, OPIc, or IELTS scores are commonly listed on Korean resumes.

recommended

Include Korean professional memberships where relevant: Korean Medical Associati

Include Korean professional memberships where relevant: Korean Medical Association (KMA), Korean Pharmaceutical Association (KPA), Korean Association of Hospital Pharmacists (KAOH), or Korean Society for the relevant therapy area.

recommended

Tailor a brief profile statement at the top in Korean (and a parallel English ve

Tailor a brief profile statement at the top in Korean (and a parallel English version) summarizing your years of experience, therapy area focus, and what makes you a fit for GSK Korea's pure-play biopharma model post-Haleon.

ATS System: GSK Global Careers Portal (Workday-based, Korean localized) or custom Korean recruitment platform

GSK Korea typically uses GSK's global Workday-based recruiting system with Korean localization for the affiliate, though some Korean affiliate roles may flow through a custom Korean recruitment portal. Applications accept both Korean and English resumes; bilingual submission is the norm. The system parses standard fields and the recruiter team in Seoul reviews matches manually given the relatively focused volume of openings versus large-volume Korean chaebol recruiting.

  • Submit both a Korean resume (이력서) and English CV — the Korean version for the local hiring team, the English version for any regional or global stakeholders involved in the loop.
  • Use exact role-keyword matches from the GSK job description (e.g., 'Medical Science Liaison', 'Market Access Manager', 'Brand Manager — Vaccines') to clear keyword filters.
  • List previous multinational pharma employers using their commonly-recognized Korean affiliate names (e.g., 'Pfizer Korea Pharmaceutical' or '한국화이자제약') so recruiter searches catch you.
  • Include MFDS, HIRA, NHIS, and NECA as explicit acronyms in your experience bullets — Korean recruiters search by these terms when filling regulatory and market access roles.
  • Avoid heavy graphic design or table-based Korean resume templates that ATS systems may parse poorly. Stick to a clean structured layout.

Interview Culture

GSK Korea interviews blend Korean professional norms with multinational corporate process discipline.

Expect respectful but rigorous conversations: hiring managers ask substantive technical and behavioral questions while observing Korean conventions of age and seniority respect, business card exchange, and structured greetings. The culture is more horizontal than Korean chaebols but more hierarchical than Western GSK offices — calibrate accordingly. For medical roles, scientific credibility is paramount. Korean physicians are scientifically demanding and MSLs need to demonstrate genuine therapeutic area depth, fluency with primary literature, and the judgment to navigate KOL relationships at top Korean academic medical centers. Be prepared to discuss specific clinical trials, mechanism of action questions, and how you would handle a contentious data discussion with a senior Korean physician. For commercial roles, expect role-plays for sales positions and brand strategy case studies for marketing — Korean pharma sales (제약영업) is a recognized career track and GSK assesses promotional skill, ethical compliance, and KOL engagement style. Market access interviews drill into the HIRA negotiation cycle — be ready to discuss reimbursement strategy, NECA HTA submissions, RSA structures, and how you would position a high-cost vaccine or specialty medicine for NHIS listing. Regulatory affairs interviews test your fluency with MFDS submission pathways, label change procedures, and post-marketing surveillance requirements. Across all roles, expect at least one interview round conducted partially or fully in English to verify your ability to communicate with the APAC regional team in Singapore and global stakeholders in London. Bilingual preparation is non-negotiable. The overall tone is professional and warm — GSK Korea has a reputation for better work-life balance than chaebols and a strong female workforce in commercial and medical functions, both of which surface naturally in the interview experience.

What GlaxoSmithKline Korea Looks For

  • Genuine therapeutic area expertise aligned to GSK's pure-play biopharma focus — HIV, oncology, respiratory and immunology, or vaccines — backed by clinical, scientific, or commercial track record.
  • Korean pharma multinational experience, with a strong preference for candidates from peer multinationals (Pfizer, MSD, Roche, Novartis, AbbVie, AstraZeneca, Takeda, Janssen, BMS, Gilead, Sanofi, Lilly Korea affiliates) or scientifically credible domestic players.
  • Bilingual Korean and English fluency — Korean for daily local work, English for APAC regional and global GSK communications. Both must be operational, not just listed on the resume.
  • Scientific rigor and evidence-based thinking — Korean physicians and MFDS reviewers expect substantive engagement with primary literature and clinical data.
  • MFDS regulatory fluency for regulatory and market access roles, plus HIRA / NHIS / NECA reimbursement system knowledge for market access candidates.
  • Korean KOL relationships at major academic medical centers (SNUH, Asan, Samsung, Severance) for medical affairs and senior commercial roles.
  • Compliance mindset — Korean Fair Trade Commission (KFTC) and CP Code (Compliance Program) compliance is taken extremely seriously in Korean pharma; any history of compliance issues is disqualifying.
  • Post-Haleon biopharma orientation — candidates should understand that GSK is no longer a consumer health company and frame their interest accordingly around vaccines and specialty medicines.
  • Cultural fit for a multinational-Korean hybrid environment — comfortable with hierarchy where it matters, capable of horizontal collaboration with global colleagues, and able to handle intense periods (HIRA negotiation cycles, vaccine launch periods).
  • Long-term career mindset — GSK Korea invests in talent development including international assignments to GSK UK or US for high performers, so demonstrated commitment and growth trajectory matters.

Frequently Asked Questions

How does GSK Korea compensation compare to Korean domestic pharma and to Korean chaebols?
GSK Korea pays competitively within the Korean multinational pharma segment, generally on par with peers like Pfizer Korea, MSD Korea, Roche Korea, and Novartis Korea. Entry-level associate roles run roughly ₩40-55M annually, mid-level brand managers and MSLs ₩60-90M, senior managers and Medical Directors ₩100-180M, and Director through VP level ₩200M and above. This is typically 20-40% above Korean domestic pharma (Yuhan, Hanmi, Daewoong) at equivalent levels and broadly comparable to Korean chaebols on base, though chaebols may offer richer year-end bonuses while multinational pharma offers superior benefits, training, and international exposure.
Does GSK Korea sponsor work visas for foreign nationals?
Yes, GSK Korea will sponsor work visas (typically E-7 specialty visas) for specialized roles where Korean talent is scarce and the candidate brings clear technical or therapy area expertise. International experience is genuinely valued. Additionally, GSK has a global mobility program — high performers in Korean affiliate roles can be considered for intra-company transfers to GSK UK, US, or APAC regional Singapore offices, which is a meaningful career development pathway.
What is the Medical Science Liaison (MSL) career path at GSK Korea?
MSL roles at GSK Korea are field-based scientific positions — typically requiring an MD, PharmD, or PhD — that engage with Korean key opinion leaders at major academic medical centers across a defined territory. MSLs cover specific therapy areas (HIV, oncology, respiratory, vaccines, immunology) and progress through Senior MSL to MSL Manager, Medical Advisor, and ultimately Medical Director roles. The career path is well-defined and scientifically respected, and Korean MSL talent often moves between GSK, Pfizer, MSD, Roche, and Novartis affiliates over a career.
What does a pharma sales rep (제약영업) career look like at GSK Korea?
Pharma sales roles at GSK Korea involve promoting products to Korean physicians at hospitals and clinics within an assigned territory. Specialty sales reps focus on narrow therapy areas (HIV, oncology, vaccines) and call on specialists at academic medical centers, while general sales reps cover broader portfolios at primary care and community settings. The career progresses from Sales Representative to Senior Rep, District Manager, and Regional Sales Manager. Korean pharma sales is a recognized professional track with structured promotional rules under KFTC and CP Code compliance.
How does the HIRA reimbursement process work and why is market access experience valued?
Market access at GSK Korea revolves around getting products listed on the National Health Insurance Service (NHIS) reimbursement schedule. The Health Insurance Review Agency (HIRA) reviews pricing and reimbursement applications, the National Evidence-based healthcare Collaborating Agency (NECA) conducts Health Technology Assessments for higher-cost products, and the Drug Reimbursement Evaluation Committee makes listing decisions. The process is rigorous and pricing is tightly controlled. Market access talent who can navigate HIRA negotiations, structure risk-sharing agreements, and build evidence dossiers for NECA HTA submissions is highly valued and well-compensated.
Does GSK Korea offer entry-level or new graduate intern programs?
Multinational pharma affiliates in Korea typically run smaller, more selective intern and entry-level programs compared to Korean chaebol mass recruitment (정기공채). GSK Korea offers internships and rotational programs in select functions (commercial, medical affairs, finance, HR) but volumes are modest — often a handful of intern positions per cycle. Most hiring is experienced lateral recruitment. New graduates with strong scientific credentials (top Korean pharmacy or medical school) and relevant internship experience are competitive.
How does GSK Korea compare to Pfizer Korea, Roche Korea, and Novartis Korea?
All four are top-tier multinational pharma affiliates in Korea with similar compensation, prestige, and talent quality, and Korean pharma professionals frequently rotate between them across a career. Differences come down to portfolio focus and culture: GSK leads in vaccines (Shingrix, Arexvy) and HIV (ViiV); Pfizer is broader with strong oncology and vaccines (Comirnaty, Prevnar); Roche dominates oncology and diagnostics; Novartis is strong in cardiovascular, ophthalmology, and innovative oncology. GSK Korea is generally seen as a balanced, scientifically credible, work-life-balanced employer.
How has the post-Haleon transformation changed what GSK Korea looks for in candidates?
Since the 2022 Haleon spinout, GSK is no longer a consumer health company — Sensodyne, Panadol, Centrum, and similar brands now belong to Haleon plc as a separately listed company. GSK Korea now hires exclusively for biopharma roles in vaccines, HIV, oncology, respiratory and immunology, and specialty medicines. Candidates with consumer healthcare backgrounds are generally not a fit unless they have transferable specialty pharma or vaccines experience. Frame your interest around GSK's innovative medicines and vaccines portfolio.
Which Korean hospitals matter most for KOL relationships at GSK Korea?
The four top-tier Korean academic medical centers carry the most weight: Seoul National University Hospital (서울대학교병원, SNUH), Asan Medical Center (서울아산병원), Samsung Medical Center (삼성서울병원), and Severance (세브란스, Yonsei). Beyond the top four, important centers include Korea University Hospital, Hanyang University Hospital, Gangnam Severance, Bundang Seoul National University Hospital, and the National Cancer Center for oncology. Therapy-area-specific KOLs at these institutions drive Korean clinical practice and reimbursement opinion.
Is Korean language fluency strictly required, or can English-only candidates work at GSK Korea?
Korean language fluency is required for nearly all GSK Korea roles. Daily work — internal meetings, KOL conversations, MFDS interactions, HIRA negotiations, sales calls, and clinical site management — happens in Korean. English fluency is also required for regional APAC and global GSK communications. The handful of roles where English-dominant candidates might fit are typically regional positions based in Korea but reporting into the APAC Singapore HQ, and even those typically require at least conversational Korean.
What is the work-life balance like at GSK Korea compared to Korean chaebols and domestic pharma?
Work-life balance at GSK Korea is generally better than Korean chaebols and at the higher end of Korean pharma overall. The multinational corporate culture limits the most extreme overtime expectations, formal 52-hour-week regulations are observed, and there's a strong female workforce in commercial and medical functions supported by progressive parental leave policies. That said, intense periods exist — HIRA negotiation cycles, vaccine launch windows, and quarter-end commercial pushes — and field-based MSL and sales roles involve significant travel to Korean hospitals and clinics.
What therapy area expertise is most in demand at GSK Korea right now?
Vaccines expertise is highly valued given Shingrix's blockbuster status and the Arexvy RSV launch. HIV expertise (ViiV portfolio) is a niche but important specialty in Korea. Oncology talent is in demand as GSK builds its oncology presence with Jemperli and Ojjaara. Respiratory and immunology specialists with Trelegy, Nucala, or Benlysta experience are competitive. Medical affairs and market access talent across all these areas is consistently sought, as is regulatory affairs talent fluent in MFDS biologics submissions for the vaccines and specialty pipeline.

Open Positions

GlaxoSmithKline Korea currently has 1 open positions.

Check Your Resume Before Applying → View 1 open positions at GlaxoSmithKline Korea

Related Resources

Similar Companies

Related Articles

Sources

  1. GSK plc — About Us —
  2. GSK Korea Affiliate Site —
  3. GSK plc Annual Report 2024 —
  4. GSK plc Renames from GlaxoSmithKline (May 2022) —
  5. Haleon plc Demerger from GSK (2022) —
  6. Reuters — GSK and Pfizer settle Zantac litigation (2024) —
  7. ViiV Healthcare — HIV Joint Venture (GSK, Pfizer, Shionogi) —
  8. GSK Vaccines — Shingrix and Arexvy —
  9. Korean Ministry of Food and Drug Safety (MFDS) — English Portal —
  10. Health Insurance Review and Assessment Service (HIRA) Korea —
  11. National Health Insurance Service (NHIS) Korea —
  12. Yakup News — Korean Pharma Industry Trade Press —
  13. GSK Careers Portal —
  14. Emma Walmsley — GSK CEO Profile —
  15. LinkedIn — GSK Korea Company Page —